Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
PepGen
PEPG
$122M
| $93.6K | ﹤0.01% |
7,655
+3,617
| +90% | +$56.6K |
|
|
IFN
4077
Aberdeen India Fund
IFN
$499M
| $93.5K | ﹤0.01% |
+6,000
| New | +$92.8K |
|
4078
Pure Cycle
PCYO
$253M
| $93.4K | ﹤0.01% |
9,884
+4,655
| +89% | +$42.9K |
|
|
ALPN
4079
DELISTED
Alpine Immune Sciences Inc
ALPN
| $93.3K | ﹤0.01% |
12,079
+5,999
| +99% | +$47.8K |
|
4080
The ONE Group
STKS
$56.2M
| $93K | ﹤0.01% |
11,485
+5,425
| +90% | +$42.7K |
|
4081
Willdan Group
WLDN
$1.04B
| $92.4K | ﹤0.01% |
5,918
+2,801
| +90% | +$50.2K |
|
4082
Nathan's Famous
NATH
$402M
| $92.3K | ﹤0.01% |
1,221
+235
| +24% | +$17.4K |
|
4083
Veritone
VERI
$101M
| $91.8K | ﹤0.01% |
15,744
+7,344
| +87% | +$50.5K |
|
4084
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.4B
| $91.1K | ﹤0.01% |
1,900
| – | – |
|
4085
Parke Bancorp
PKBK
$401M
| $90.5K | ﹤0.01% |
5,090
+2,376
| +88% | +$47.3K |
|
4086
Velocity Financial
VEL
$689M
| $90.4K | ﹤0.01% |
10,012
+7,300
| +269% | +$69.7K |
|
4087
Ring Energy
REI
$315M
| $90.4K | ﹤0.01% |
47,563
+22,249
| +88% | +$48K |
|
4088
Northeast Community Bancorp
NECB
$368M
| $90.4K | ﹤0.01% |
6,887
+4,705
| +216% | +$70.5K |
|
4089
First Community Corp
FCCO
$321M
| $90.1K | ﹤0.01% |
4,505
| – | – |
|
|
GDEV
4090
DELISTED
Nexters Inc. Ordinary Shares
GDEV
| $89.7K | ﹤0.01% |
13,218
+1,800
| +16% | +$12.2K |
|
|
GHL
4091
DELISTED
Greenhill & Co., Inc.
GHL
| $89.5K | ﹤0.01% |
10,092
+6,636
| +192% | +$75.5K |
|
4092
Phathom Pharmaceuticals
PHAT
$708M
| $89.4K | ﹤0.01% |
12,526
+3,647
| +41% | +$32K |
|
4093
Valaris Ltd Warrants
VAL.WS
$684M
| $89.3K | ﹤0.01% |
8,116
| – | – |
|
4094
Aurora
AUR
$12.6B
| $89.3K | ﹤0.01% |
64,218
| – | – |
|
4095
Tilly's
TLYS
$116M
| $88.8K | ﹤0.01% |
11,522
+5,451
| +90% | +$45.6K |
|
4096
Energy Vault
NRGV
$517M
| $88.6K | ﹤0.01% |
41,414
+19,398
| +88% | +$66.2K |
|
|
FRGI
4097
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $88.5K | ﹤0.01% |
10,770
| – | – |
|
4098
Precigen
PGEN
$2.24B
| $88.5K | ﹤0.01% |
83,491
+34,484
| +70% | +$49.7K |
|
4099
Outdoor Holding Co
POWW
$249M
| $88.4K | ﹤0.01% |
44,890
+21,136
| +89% | +$43.7K |
|
4100
Blue Ridge Bankshares
BRBS
$315M
| $87.9K | ﹤0.01% |
8,621
+4,050
| +89% | +$48.1K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.